Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 152095-12-0 Chemical Structure| 152095-12-0

Structure of Dp44mT
CAS No.: 152095-12-0

Chemical Structure| 152095-12-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Dp44mT is a potent iron chelator, which shows selective antitumor activity.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Dp44mT

CAS No. :152095-12-0
Formula : C14H15N5S
M.W : 285.37
SMILES Code : S=C(NN=C(C1=NC=CC=C1)C2=NC=CC=C2)N(C)C
MDL No. :MFCD20527329
InChI Key :XOBIGRNRXCAMJQ-UHFFFAOYSA-N
Pubchem ID :10334137

Safety of Dp44mT

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P301+P310
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RD rhabdomyosarcoma cells 7.2 nM 72 hours Evaluated the antiproliferative effect of Dp44mT, showing significant inhibition on RD cells Front Pharmacol. 2022 Sep 7;13:976955
Saos-2 osteosarcoma cells 15.3 nM 72 hours Evaluated the antiproliferative effect of Dp44mT, showing significant inhibition on Saos-2 cells Front Pharmacol. 2022 Sep 7;13:976955
DAOY medulloblastoma cells 11.1 nM 72 hours Evaluated the antiproliferative effect of Dp44mT, showing significant inhibition on DAOY cells Front Pharmacol. 2022 Sep 7;13:976955
SK-N-BE(2) neuroblastoma cells 2.3 nM 72 hours Evaluated the antiproliferative effect of Dp44mT, showing significant inhibition on SK-N-BE(2) cells Front Pharmacol. 2022 Sep 7;13:976955
SH-SY5Y neuroblastoma cells 1.1 nM 72 hours Evaluated the antiproliferative effect of Dp44mT, showing significant inhibition on SH-SY5Y cells Front Pharmacol. 2022 Sep 7;13:976955
RD rhabdomyosarcoma cells 9.4 μM 24 h To evaluate the synergistic effect of Dp44mT with anthracyclines, showing synergistic effects Int J Mol Sci. 2022 Aug 1;23(15):8549
Daoy medulloblastoma cells 7.9 μM 24 h To evaluate the synergistic effect of Dp44mT with anthracyclines, showing synergistic effects Int J Mol Sci. 2022 Aug 1;23(15):8549
Saos-2 osteosarcoma cells 6.6 μM 24 h To evaluate the synergistic effect of Dp44mT with anthracyclines, showing moderate antagonism Int J Mol Sci. 2022 Aug 1;23(15):8549
SK-N-BE(2) neuroblastoma cells 4.2 μM 24 h To evaluate the synergistic effect of Dp44mT with anthracyclines, showing synergistic effects Int J Mol Sci. 2022 Aug 1;23(15):8549
SH-SY5Y neuroblastoma cells 1.9 μM 24 h To evaluate the synergistic effect of Dp44mT with anthracyclines, showing synergistic effects Int J Mol Sci. 2022 Aug 1;23(15):8549
SH-SY5Y 25 μM 24 hours To evaluate the apoptosis-inducing effect of Dp44mT on non-MYCN-amplified neuroblastoma cells, results showed that Dp44mT significantly increased early and late apoptosis in SH-SY5Y cells. J Hematol Oncol. 2016 Sep 27;9(1):98
SK-N-AS 25 μM 24 hours To evaluate the apoptosis-inducing effect of Dp44mT on non-MYCN-amplified neuroblastoma cells, results showed that Dp44mT significantly increased early and late apoptosis in SK-N-AS cells. J Hematol Oncol. 2016 Sep 27;9(1):98
BE(2)C 25 μM 24 hours To evaluate the apoptosis-inducing effect of Dp44mT on MYCN-amplified neuroblastoma cells, results showed that Dp44mT significantly increased early and late apoptosis in BE(2)C cells. J Hematol Oncol. 2016 Sep 27;9(1):98
SK-N-LP 25 μM 24 hours To evaluate the anti-proliferative activity of Dp44mT on neuroblastoma cells, results showed that Dp44mT significantly inhibited the proliferation of SK-N-LP cells. J Hematol Oncol. 2016 Sep 27;9(1):98
HCT-15 cells 0.1–10μM 24 hours To evaluate the cytotoxicity of Dp44mT on colon cancer cells and its effect on Pgp protein levels. Results showed Dp44mT had significant cytotoxicity on HCT-15 cells. Cell Death Dis. 2016 Dec 1;7(12):e2510
MDA-MB-231 cells 0.1–10μM 24 hours To evaluate the cytotoxicity of Dp44mT on breast cancer cells and its effect on Pgp protein levels. Results showed Dp44mT had significant cytotoxicity on MDA-MB-231 cells. Cell Death Dis. 2016 Dec 1;7(12):e2510
MCF7 cells 0.1–10μM 24 hours To evaluate the cytotoxicity of Dp44mT on breast cancer cells and its effect on Pgp protein levels. Results showed Dp44mT had significant cytotoxicity on MCF7 cells. Cell Death Dis. 2016 Dec 1;7(12):e2510
KB31 cells 0.1–10μM 24 hours To evaluate the cytotoxicity of Dp44mT on low Pgp-expressing cells and its effect on Pgp protein levels. Results showed Dp44mT had lower cytotoxicity on KB31 cells. Cell Death Dis. 2016 Dec 1;7(12):e2510
KBV1 cells 0.1–10μM 24 hours To evaluate the cytotoxicity of Dp44mT on Pgp-expressing cells and its effect on Pgp protein levels. Results showed Dp44mT significantly decreased Pgp expression and selectively killed Pgp-expressing cells. Cell Death Dis. 2016 Dec 1;7(12):e2510
MDA-MB-157 breast cancer cells 5 μM 48-72 hours Induced cytoplasmic vacuolation and lipid droplet accumulation, consistent with MDA-MB-231 phenotype J Exp Clin Cancer Res. 2018 Apr 3;37(1):75
MDA-MB-231 breast cancer cells 5 μM 48-72 hours Induced cytoplasmic vacuolation and lipid droplet accumulation, leading to non-apoptotic cell death J Exp Clin Cancer Res. 2018 Apr 3;37(1):75
OECM-1 cells 0-20 µM 24 hours Dp44mT significantly inhibited OECM-1 cell growth and upregulated NDRG1 and NDRG3 protein expressions. Int J Mol Sci. 2016 Aug 31;17(9):1435
SAS cells 0-20 µM 24 hours Dp44mT significantly inhibited SAS cell growth, partly due to induction of G1 cell cycle arrest. Int J Mol Sci. 2016 Aug 31;17(9):1435

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Xenograft model Intravenous injection 0.5 mg/kg Once daily for 17 days Dp44mT significantly inhibited tumor growth of SAS cells in vivo without affecting body weight of mice. Int J Mol Sci. 2016 Aug 31;17(9):1435

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.50mL

0.70mL

0.35mL

17.52mL

3.50mL

1.75mL

35.04mL

7.01mL

3.50mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories